✦ LIBER ✦

Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen

✍ Scribed by Cécile Fohrer; Sophie Caillard; Argyro Koumarianou; Bernard Ellero; Marie-Lorraine Woehl-Jaeglé; Carole Meyer; Eric Epailly; Marie-Pierre Chenard; Bruno Lioure; Shanti Natarajan-Ame; Frédéric Maloisel; Philippe Lutun; Romain Kessler; Bruno Moulin; Jean-Pierre Bergerat; Philippe Wolf; Raoul Herbrecht

Book ID: 108673893
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 518 KB
Volume: 134
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2006.06228.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of a high-dose ifosfamide

Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival

✍ van Besien, K; Rodriguez, A; Tomany, S; Younes, A; Donato, M; Sarris, A; Giralt, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 96 KB

High-dose therapy and autologous stem ce

High-dose therapy and autologous stem cell transplant does not result in long-term disease-free survival in patients with recurrent chemotherapy-sensitive ALK-negative anaplastic large-cell lymphoma

✍ Zamkoff, K W; Matulis, M D; Mehta, A C; Beaty, M W; Hutchison, R E; Gentile, T C 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 103 KB